Clinical trial
Prospective Observational Study Investigating the Cardiotoxicity of Anthracyclines in Patients With Diffuse Large B-Cell
NCT02916316 is registered in ClinicalTrials.gov with Fondazione Italiana Linfomi - ETS as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prospective Observational Study Investigating the Cardiotoxicity of Anthracyclines in Patients With Diffuse Large B-Cell
- Lead sponsor
- Fondazione Italiana Linfomi - ETS
- Phase
- Observational
- Overall status
- Completed
- Start date
- February 12, 2014
- Completion date
- December 31, 2024
- Enrollment
- 127 (actual)
- Sites
- 18
Conditions
As the registry lists them; a condition with its own page is linked.
diffuse large b-cell, large b-cell, lymphoma